Navegador (Portugal)
Drug Discovery & Preclinical Development
Visit websiteFrom molecule to first clinical data
Diagenta runs early-phase clinical trials in Australia, with PK/PD analysis in our own Sydney laboratory.
We take your study from protocol to first participant dosed, and deliver PK data without hand-offs between vendors.
image slotwhy-australia
Why start in Australia
A well-established pathway for early-phase trials, combined with a significant R&D incentive for eligible companies.
No US IND needed to start
Trials run under the TGA's Clinical Trial Notification (CTN) scheme, after approval from a Human Research Ethics Committee.
Up to 43.5% refundable R&D tax offset1
For eligible companies with aggregated turnover under A$20 million.
Data accepted by FDA and EMA
For studies conducted to ICH Good Clinical Practice.
Fast site activation2
Typical start-up from ethics submission with a private ethics committee.
1 Rates and eligibility are set by the Australian Taxation Office. Reforms have been announced for income years starting from 1 July 2028. General information, not tax advice. 2 Depends on the ethics committee, site and study design.
Our competencies
image slotcomp-strategy
16:9
- Development strategy & protocol planning
- Feasibility & study start-up
- Regulatory & ethics support
- Vendor and study planning
image slotcomp-delivery
16:9
- Project and clinical operations management
- Site coordination & monitoring
- Medical & safety oversight
- Vendor coordination & data review
image slotcomp-bioanalysis
16:9
- PK/PD strategy and study planning
- Sampling and analytical strategy
- Small-molecule method development and validation
- PK sample analysis capability being developed in Australia
image slotlabs-bg — фон секции
широкое фото
Integrated labs
In-house PK/PD and safety labs deliver lightning-fast accurate results with custom assay development and automated analysis.
image slotlabs
Part of Rambam Group. Supporting drug development from preclinical to late-stage clinical trials.
Through Rambam Group's integrated network, Diagenta connects preclinical expertise, early-phase clinical development, and global clinical trial capabilities.
More about Rambam GroupDiagenta (Australia)
Early-Phase Clinical Trials & PK/PD Bioanalysis
You're already hereRambac (Uzbekistan)
Phase I–IV Clinical Trials & Patient Recruitment
Visit website
image slotclients
Who we work with
We work with a wide variety of clients across multiple industries.
- Biotech and pharma innovators
- Medtech and device developers
- CROs and academic institutions
- State and federal agencies
- Patient advocacy groups
Ready to accelerate your trial in Australia?
Join the innovation leaders who trust Diagenta to bring breakthrough therapies to market faster than ever before.